Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-01Clinical Trial Update: Multiple Sclerosis, Sarcopenia and Respiration
This record announces the completion of a Uskudar University–sponsored clinical trial on multiple sclerosis with assessments of sarcopenia a…
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: Safety of Bryostatin in Patients With MS [Phase 1]
A Phase 1 safety trial evaluating Bryostatin in people with multiple sclerosis was terminated; results have been posted.
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: Evaluation of Interoception, Fatigue, and Upper and Lower Extremity Functional Capacity in Multiple Sclerosis Patients With Good and Poor Sleep Quality
This completed clinical trial evaluated how interoception, fatigue, and upper- and lower-extremity functional capacity relate to sleep quali…
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: Clinical Efficacy of a telerehabilItation Protocol, for the Improvement of Balance in Degenerative Neurological Diseases [NA]
A clinical trial update reports on the efficacy of a telerehabilitation protocol to improve balance in degenerative neurological diseases, i…
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: Effect of Low Histamine-Based Modified Mediterranean Diet in Multiple Sclerosis [NA]
Clinical trial update confirming the completion of a study assessing the impact of a low histamine-based modified Mediterranean diet on rela…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: Effects of Mat and Reformer Pilates in Multiple Sclerosis [NA]
A Gazi University clinical trial evaluating the effects of Mat and Reformer Pilates in people with Multiple Sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Effects of Ocrelizumab Treatment on Immune Cells in Lymph Nodes in Multiple Sclerosis [Phase 4]
Phase 4 clinical trial update on ocrelizumab in relapsing-remitting multiple sclerosis, describing its effects on immune cells in lymph node…
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: A Self-management Program to Prevent Falls in People With Multiple Sclerosis [NA]
A completed clinical trial evaluated a self-management program aimed at preventing falls in people with multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2026-03-25Clinical Trial Update: Multiple Sclerosis, Menstrual Cycle and Physical Acivity [NA]
The clinical trial investigating the relationship between the menstrual cycle and physical activity in individuals with multiple sclerosis h…
-
CLINICAL_TRIALS trial_result · 2026-03-20Clinical Trial Update: Effects of Pelvic Floor Strengthening and Relaxation Exercises in Women Diagnosed With Multiple Sclerosis [NA]
A completed clinical trial from Gazi University assessed the effects of pelvic floor strengthening and relaxation exercises in women with mu…
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: MS Relapses During COVID-19 Pandemic
A completed clinical trial studying relapses in multiple sclerosis during the COVID-19 pandemic.
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: Prevalence of Periodontitis in Egyptian Multiple Sclerosis Patients.
A completed clinical trial from Cairo University evaluating the prevalence of periodontitis in Egyptian patients with multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: Electrical Brain Stimulation for Treatment of Secondary Symptoms in Multiple Sclerosis [NA]
A clinical trial evaluating electrical brain stimulation for secondary symptoms in multiple sclerosis has completed. Sponsor: The National B…
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: Evaluation of Early Changes Visible to the Diffusion MRI in Response to Two Years of Treatment With Tysabri in Patients With Multiple Sclerosis [Phase 4]
A Phase 4 clinical trial evaluating early diffusion MRI changes after two years of treatment with natalizumab (Tysabri) in patients with mul…
-
CLINICAL_TRIALS trial_result · 2026-03-12Clinical Trial Update: Use of Inertial Units in Patient With Multiple Sclerosis (IMUSEP)
A completed clinical trial evaluating inertial units as a medical device to assist balance and coordination in people with Multiple Sclerosi…
-
CLINICAL_TRIALS trial_result · 2026-03-11Clinical Trial Update: Impact of Neuropsychological Disorders in Multiple Sclerosis [NA]
This clinical trial update indicates the study on neuropsychological disorders in multiple sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2026-03-11Clinical Trial Update: Evaluation of a Spasticity Management Program for People With Multiple Sclerosis [NA]
A completed VA Office of Research and Development–sponsored clinical trial evaluated a spasticity management program for people with Multipl…
-
CLINICAL_TRIALS trial_result · 2026-03-10Clinical Trial Update: DreaMS - Validation Study 1
Status update for the DreaMS Validation Study 1 showing the trial is currently active but not recruiting for Multiple Sclerosis.
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: Impact of Adding Cognitive Behaviour Therapy to Supervised Pilates-based Core Stability Training in Patients With Multiple Sclerosis [NA]
A completed clinical trial evaluating whether adding cognitive behavioral therapy to supervised Pilates-based core stability training improv…
-
CLINICAL_TRIALS trial_result · 2026-03-03Clinical Trial Update: Open Label Randomized Multicenter to Assess Efficacy & Tolerability of Ofatumumab 20mg vs. First Line DMT in RMS [Phase 3]
A completed Phase 3 open-label trial comparing ofatumumab 20 mg with a first-line disease-modifying therapy in relapsing multiple sclerosis …
-
CLINICAL_TRIALS trial_result · 2026-03-02Clinical Trial Update: ADAs to Alemtuzumab
This clinical trial update reports on anti-drug antibodies (immunogenicity) observed with alemtuzumab in people with multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell ( CAR-T) Therapy in Subjects With Non-relapsing and Progressive Forms of Multiple Sclerosis [Phase 1]
A Phase 1 clinical trial sponsored by Stanford University is evaluating anti-CD19 CAR-T cell therapy for non-relapsing and progressive forms…
-
CLINICAL_TRIALS trial_result · 2026-02-25Clinical Trial Update: Determine PK Profiles of Ozanimod and Its' Major Metabolites in Healthy Subjects
This completed clinical trial evaluated the pharmacokinetics of ozanimod and its major metabolites in healthy subjects to characterize expos…
-
CLINICAL_TRIALS trial_result · 2026-02-23Clinical Trial Update: Amygdala Insula Retraining in the Management of Multiple Sclerosis Symptoms [NA]
This entry notes that a clinical trial evaluating amygdala-insula retraining for managing Multiple Sclerosis symptoms has completed.
-
CLINICAL_TRIALS trial_result · 2026-02-20Clinical Trial Update: Safety and Efficacy of Melatonin in Patients With Multiple Progressive Primary Sclerosis [Phase 1, Phase 2]
Clinical trial update assessing safety and efficacy of melatonin in patients with multiple sclerosis, including primary progressive multiple…